BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao L, Wu ZX, Assaraf YG, Chen ZS, Wang L. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function. Drug Resist Updat 2021;57:100770. [PMID: 34175687 DOI: 10.1016/j.drup.2021.100770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Su Z, Dong S, Zhao SC, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen ZS, Zou C. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat 2021;58:100777. [PMID: 34481195 DOI: 10.1016/j.drup.2021.100777] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bueschbell B, Caniceiro AB, Suzano PM, Machuqueiro M, Rosário-ferreira N, Moreira IS. Network Biology and Artificial Intelligence Drive the Understanding of the Multidrug Resistance Phenotype in Cancer. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100811] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: An update and perspective. Drug Resist Updat 2021;:100796. [PMID: 34953682 DOI: 10.1016/j.drup.2021.100796] [Reference Citation Analysis]
4 Chen S, Zhao Y, Liu S, Zhang J, Assaraf YG, Cui W, Wang L. Epigenetic enzyme mutations as mediators of anti-cancer drug resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Feng C, Lyu Y, Gong L, Wang J. Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review. Nutrients 2022;14:2274. [DOI: 10.3390/nu14112274] [Reference Citation Analysis]
6 Cao Y, -Zhu L, Zhang H, Meng J, Wu H, Wang X, Wu J, Zou J, Fang M, An J, Chen Y. Total Barley Maiya Alkaloids Prevent Increased Prolactin Levels Caused by Antipsychotic Drugs and Reduce Dopamine Receptor D2 via Epigenetic Mechanisms. Front Pharmacol 2022;13:888522. [DOI: 10.3389/fphar.2022.888522] [Reference Citation Analysis]
7 Fan Z, Rong Y, Sadhukhan T, Liang S, Li W, Yuan Z, Zhu Z, Guo S, Ji S, Wang J, Kushwaha R, Banerjee S, Raghavachari K, Huang H. Single‐Cell Quantification of a Highly Biocompatible Dinuclear Iridium(III) Complex for Photocatalytic Cancer Therapy. Angewandte Chemie. [DOI: 10.1002/ange.202202098] [Reference Citation Analysis]
8 Xavier CP, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, Vasconcelos MH. The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang W, Wang J, Liu S, Ren Y, Wang J, Liu S, Cui W, Jia L, Tang X, Yang J, Wu C, Wang L. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer. Mol Cancer 2022;21:106. [PMID: 35477569 DOI: 10.1186/s12943-022-01579-9] [Reference Citation Analysis]
10 Hare L, Burke GAA, Turner SD. Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL. Cancers (Basel) 2021;13:6003. [PMID: 34885113 DOI: 10.3390/cancers13236003] [Reference Citation Analysis]